Heliospectra announces about the new order the company has received from an Australian manufacturer and researcher of controlled substances, who supply products and services to the international pharmaceutical industry. The Australian company will install Heliospectra’s ELIXIA LED grow light solution in its Conviron cannabis grow-rooms for related researches and has invested around USD 78,000 on the same.
The researchers perform studies by controlling all the characteristics that may lead the growth of cannabis and attempt to find approaches to achieve higher yield and boost the quality of corps. The ultimate goal is to produce cost-effective cannabinoid pharmaceuticals for end –customers.
“For cannabis cultivation, production of highest-quality crops and the ability to control compounds is of utmost importance as facilities scale. These include the ability to influence terpenes and control THC and CBD levels,” said Ali Ahmadian, CEO of Heliospectra. “Utilizing our controllable ELIXIA light helps our research customers and commercial growers to be flexible yet reach their production objectives faster.”
Heliospectra’s LED makes clear business benefits for cultivation groups and researchers around the globe. The completely adjustable LED lighting solution is good with Heliospectra’s HelioCORE™ light control programming, empowering cultivators to enhance the nature of plants and quicken harvest and production cycles while giving steady and standardised returns.
